Moderna Sues Pfizer, BioNTech For Patent Infringement

Moderna Inc. (MRNA) said on Friday that it is filing lawsuits against Pfizer Inc. (PFE) and BioNTech SE (BNTX), alleging that their Covid-19 vaccine Comirnaty, infringes the patents that it had filed between 2010 and 2016 covering its foundational mRNA technology.

The patent infringement lawsuits have been filed in the U.S. District Court for the District of Massachusetts, and the Regional Court of Düsseldorf in Germany.

The pharma major said that its foundational mRNA technology was critical for the development of its own mRNA Covid-19 vaccine, Spikevax. "Pfizer and BioNTech copied this technology, without Moderna's permission, to make Comirnaty," Moderna said in a statement.

However, the drug maker noted that it is not pursuing monetary damages on sales to the 92 low- and middle-income countries in the GAVI COVAX Advance Market Commitment (AMC 92).

It is also said that Moderna is not seeking to remove Comirnaty from the market and prevent its future sale nor is it claiming damages for the activities reported before March 8.

In a bid to provide equitable access, Moderna had decided not to enforce its Covid-19 related patents when the pandemic continued. In March, the company clarified in an update that it would never enforce its patents for any Covid-19 vaccine used in the 92 low- and middle-income countries in the GAVI COVAX AMC 92.

Moderna expected that Pfizer and BioNTech would respect its intellectual property rights and would consider a commercially reasonable license. However, the two drug makers have failed to do so, says the lawsuit.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Apple Inc. plans to start using American-made processors from the new advanced chip factory in Phoenix, Arizona operated by chip giant Taiwan Semiconductor Manufacturing Co., according to its Chief Executive Officer Tim Cook. At an event in the factory in Arizona, which was attended by U.S. President Joe Biden, it was also announced that TSMC will invest $40 billion in the new factory. Lidl US has recalled its 8.4 oz Favorina branded Advent Calendar, i.e., Premium Chocolate with a Creamy Filling, citing potential Salmonella contamination, the U.S. Food and Drug Administration said. The products were available for sale at Lidl stores between October 12, 2022 and December 5, 2022. They will have a BEST IF USED BY year of 2023, and barcode number of 4056489516965. Vaccine partners Pfizer Inc. and BioNTech SE are seeking emergency use authorization or EUA from the U.S. Food and Drug Administration to offer their bivalent COVID-19 vaccine to children 6 months through 4 years of age. If authorized, the vaccine would be part of a primary series for children in this age group.
Follow RTT